Company: ENTXW
Filing Date: 2025-06-05
Form Type: DEF 14A
Source: 0001178913-25-002111
Chunk: 37

Company: Entera Bio Ltd.
Filing Date: 2025-06-05
Form: DEF 14A
Chunk 37
---
i) 46,936 Ordinary Shares and (ii) 388,676Ordinary Shares underlying options to acquire Ordinary Shares. |

| (12) | Consists of (i) 86,729 Ordinary Shares and (ii) 321,771Ordinary Shares underlying options to acquire Ordinary Shares. |

| (13) | Consists of (i) 50,000 Ordinary Shares, (ii) 25,126 Ordinary Shares underlying RSUs and (iii) 206,150 Ordinary Shares underlying options to acquire Ordinary Shares. |

| (14) | Consists of (i)64,650 Ordinary Shares and (ii) 145,013Ordinary Shares underlying options to acquire Ordinary Shares. |

| (15) | Consists of (i) 900,119 Ordinary Shares, (ii) 23,952 Ordinary Shares underlying warrant to acquire Ordinary Shares, (iii) 205,714 Ordinary Shares underlying RSUs and (iv) 4,030,935 Ordinary Shares underlying options to acquire Ordinary Shares. |

Entera Bio Ltd. | 2025 Annual Meeting Proxy Statement 20

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE Section 16(a) of the Exchange Act and the rules thereunder require that our directors and executive officers and persons who beneficially own more than 10% of a registered class of our equity securities (collectively, “reporting persons”) file reports with the SEC relating to their share ownership and changes in such ownership. Based solely upon our review of copies of filings or written representations from the reporting persons, we believe that all reporting persons timely filed all reports required by them under Section 16(a) of the Exchange Act with respect to the year ended December 31, 2024. Entera Bio Ltd. | 2025 Annual Meeting Proxy Statement 21

| SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATIONPLANS |

The following table provides certain information as of December 31, 2024, with respect to our equity compensation plans under which our equity securities are authorized for issuance:

| Plan Category                                              
 Equity compensation plans approved by security holders     |     | Number of securities to be issued upon exercise of outstanding options, RSUs, warrants and rights 
 (#)                                                                                               
 (a)                                                                                               |           |     | Weighted-average exercise price of outstanding options, RSUs, 
 warrants and rights                                           
 ($)                                                           
 (b)                                                           |      |     |